Ballicules › Drugs › Disulfiram
What it is Irreversible aldehyde dehydrogenase inhibitor; alcohol use disorder.
Why this one It works by deterrence rather than craving reduction, which suits supervised administration.
What limits it The alcohol reaction can be severe and requires full informed consent and avoidance of hidden alcohol. Hepatotoxicity and neuropathy.
FDA-approved for
alcohol use disorder (1951)
FDA label
Read the full label on DailyMed ↗
BOXED WARNING Never administer to a patient who is intoxicated or without the patient's full knowledge.
FDA dosing Population Start Target Max
Adjunct in management of chronic alcoholism (support abstinence) Adult Up to 500 mg QD x1–2 weeks 250 mg QD (range 125–500 mg) 500 mg/day
Renal Undefined
Hepatic Undefined
Instructions Never administer until the patient has abstained from alcohol for at least 12 hours May take at bedtime if sedating; adjust dose downward to minimize sedation Continue daily, uninterrupted; maintenance may be required for months to years
Contraindications Recent or current metronidazole Recent or current paraldehyde Alcohol or alcohol-containing preparations (e.g., cough syrups, tonics) Severe myocardial disease or coronary occlusion Psychoses
Cautions Hepatotoxicity — hepatitis and hepatic failure (transplant/death reported) Optic neuritis, peripheral neuritis/neuropathy Psychotic reactions (esp. high dose or combined toxicity) Disulfiram-alcohol reaction — can be severe
Adverse reactions Drowsiness/fatigability Impotence Headache Acneform eruptions, allergic dermatitis Metallic or garlic-like aftertaste Optic/peripheral neuritis Hepatitis
Pregnancy Safe use in pregnancy not established; use only if probable benefits outweigh possible risks.
Lactation Undefined
⚠ BOXED WARNING
Never administer to an intoxicated patient or without their knowledge
Cost, est. cash $10–$300/month
Generic entry 1983
Classes and tags
Clinical profile
Therapeutic safety burden 1 / 4
Overdose danger 1 / 4
Weight-gain liability 0 / 4
Sedation liability 0 / 4
QT / Torsades 0 / 4
Direct muscarinic antagonism 0 / 4
Embryofetal risk 1 / 4
Legacy pregnancy category Unknown / historical label unavailable
Defining liability Generally tolerated at therapeutic doses; clinically important risks are agent-specific and increase with interactions or organ impairment.
Mechanism of action: Disulfiram ballicule
Open Disulfiram in the interactive console ↗
Memory aids: mascots and interaction avatars
“Ant abuse; Die sufferin’”
Box: minimal PK interactions
Open Disulfiram in the interactive console ↗